Physician profile
Luz E Colon
NPI 1134182538
$2,012.30
in general payments reported to CMS, 2019-2025
11 companies · $522 in 2025
The $522 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $552 · 2020: $33.10 · 2021: $278 · 2022: $348 · 2023: $258 · 2024: $21.38 · 2025: $522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $553 · Travel and Lodging: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $552.56 |
| Travel and Lodging | $248.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $516.00 | 2019 | |
| Organogenesis INC. | $374.67 | 2021-2025 | Puraply Wound Matrix, Puraply, Cygnus Dual |
| Acera Surgical, INC. | $324.00 | 2022 | |
| Treace Medical Concepts, INC. | $252.60 | 2025 | |
| Kerecis Limited | $125.70 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Biotissue Holdings INC. | $122.29 | 2023 | |
| Smith+Nephew, INC. | $100.06 | 2021-2025 | Collagenase Santyl |
| Stryker Corporation | $71.15 | 2019-2025 | Prostep |
| Pacira Pharmaceuticals Incorporated | $52.96 | 2025 | Exparel |
| Paratek Pharmaceuticals, INC. | $39.77 | 2024-2025 | Nuzyra |
| Hartmann USA, INC. | $33.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luz Colon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.